TW202320736A - 用於製備脂質奈米粒子組成物之製程 - Google Patents

用於製備脂質奈米粒子組成物之製程 Download PDF

Info

Publication number
TW202320736A
TW202320736A TW111127849A TW111127849A TW202320736A TW 202320736 A TW202320736 A TW 202320736A TW 111127849 A TW111127849 A TW 111127849A TW 111127849 A TW111127849 A TW 111127849A TW 202320736 A TW202320736 A TW 202320736A
Authority
TW
Taiwan
Prior art keywords
composition
lipid
lipid nanoparticle
buffer
empty
Prior art date
Application number
TW111127849A
Other languages
English (en)
Chinese (zh)
Inventor
麥可 H 史密斯
尼米爾 素德
田暢
丹尼爾 W 多爾蒂
Original Assignee
美商現代公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商現代公司 filed Critical 美商現代公司
Publication of TW202320736A publication Critical patent/TW202320736A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW111127849A 2021-07-26 2022-07-25 用於製備脂質奈米粒子組成物之製程 TW202320736A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163225815P 2021-07-26 2021-07-26
US63/225,815 2021-07-26

Publications (1)

Publication Number Publication Date
TW202320736A true TW202320736A (zh) 2023-06-01

Family

ID=82899410

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111127849A TW202320736A (zh) 2021-07-26 2022-07-25 用於製備脂質奈米粒子組成物之製程

Country Status (6)

Country Link
US (1) US20240335393A1 (cg-RX-API-DMAC7.html)
EP (1) EP4376814A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527939A (cg-RX-API-DMAC7.html)
CN (1) CN118019527A (cg-RX-API-DMAC7.html)
TW (1) TW202320736A (cg-RX-API-DMAC7.html)
WO (1) WO2023009421A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020002348A (es) 2017-08-31 2020-10-08 Modernatx Inc Métodos de elaboración de nanopartículas lipídicas.
CN113939282A (zh) 2019-01-31 2022-01-14 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
WO2025103414A1 (zh) * 2023-11-14 2025-05-22 上海瑞宏迪医药有限公司 一种脂质纳米粒的制备方法和应用
WO2025214340A1 (zh) * 2024-04-08 2025-10-16 苏州艾博生物科技有限公司 脂质纳米颗粒制剂及其制备方法
GB2702140A (en) 2024-10-10 2026-06-03 Apoha Ltd Method and apparatus
WO2026153419A1 (en) * 2025-01-16 2026-07-23 Suzhou Abogen Biosciences Co., Ltd. Lipid nanoparticle compositions and processes of preparing the same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
WO2006044660A2 (en) * 2004-10-14 2006-04-27 Vanderbilt University Functionalized solid lipid nanoparticles and methods of making and using same
RU2573409C2 (ru) * 2009-11-04 2016-01-20 Дзе Юниверсити Оф Бритиш Коламбиа Содержащие нуклеиновые кислоты липидные частицы и относящиеся к ним способы
EP2857499A1 (en) 2010-10-01 2015-04-08 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
US9999673B2 (en) 2011-01-11 2018-06-19 Alnylam Pharmaceuticals, Inc. PEGylated lipids and their use for drug delivery
WO2013086322A1 (en) * 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
WO2014093924A1 (en) 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
PT2922554T (pt) 2012-11-26 2022-06-28 Modernatx Inc Arn modificado nas porções terminais
WO2014164253A1 (en) 2013-03-09 2014-10-09 Moderna Therapeutics, Inc. Heterologous untranslated regions for mrna
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
WO2017031232A1 (en) * 2015-08-17 2017-02-23 Modernatx, Inc. Methods for preparing particles and related compositions
HRP20220156T1 (hr) * 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
DK3386484T3 (da) 2015-12-10 2022-07-04 Modernatx Inc Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
US12076439B2 (en) * 2018-05-24 2024-09-03 Translate Bio, Inc. Thioester cationic lipids
DK3864163T3 (da) * 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
EP4031524A1 (en) * 2019-09-19 2022-07-27 ModernaTX, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents

Also Published As

Publication number Publication date
CN118019527A (zh) 2024-05-10
US20240335393A1 (en) 2024-10-10
EP4376814A1 (en) 2024-06-05
WO2023009421A1 (en) 2023-02-02
JP2024527939A (ja) 2024-07-26

Similar Documents

Publication Publication Date Title
TW202320737A (zh) 製備用於將酬載分子遞送至氣道上皮之脂質奈米粒子組成物之製程
US20240335393A1 (en) Processes for preparing lipid nanoparticle compositions
EP3852728B1 (en) Preparation of lipid nanoparticles and methods of administration thereof
ES2992653T3 (en) Methods of preparing lipid nanoparticles
US11786607B2 (en) RNA formulations
TW202139976A (zh) 製備脂質奈米顆粒之方法
TW202214215A (zh) 用於將有效負載分子遞送至氣道上皮之組成物
JP2019519601A (ja) 急性間欠性ポルフィリン症の治療のためのポルホビリノゲン脱アミノ酵素をコードするポリヌクレオチド
WO2018089540A1 (en) Stabilized formulations of lipid nanoparticles
JP2019519511A (ja) Ii型シトルリン血症の治療のためのシトリンをコードするポリヌクレオチド
WO2017106799A1 (en) POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE
WO2023086465A9 (en) Compositions for the delivery of payload molecules to airway epithelium
US20250214046A1 (en) Cross mixers for lipid nanoparticle production, and methods of operating the same
TW202345870A (zh) 具有延長半衰期之信使核糖核酸
US20250049728A1 (en) Processes for preparing lipid nanoparticles
WO2024091918A2 (en) Methods of lipid nanoparticle production in cross-mixers
EP4683666A1 (en) Peg targeting compounds for delivery of therapeutics
WO2024197310A1 (en) Peg targeting compounds for delivery of therapeutics
US20260014281A1 (en) Peg targeting compounds for delivery of therapeutics